1Kim C9. Pancreatitis - etiology and pathogenesis [ J ]. Korean J Gastroenterol, 2005,46(5) :321.
2Weber CK, Adler G. From a cinar cell damage to systemic inflammatory response : current concept sin panereatitis [ J ]. Pancreatology,2001, 1 (4) :356.
3Algul H, Tando Y, Schneider G, et al. Acute experimental pancreatitis and NF - Kappa B/Relactivation [ J]. Pancreatology, 2002,2(6) :503.
4Chen LF,Greene WC. Shaping the nuclear action of NF - Kappa B[J]. Nat Rev Mol Cell Biol,2004,5: 392.
7Storz P,Toker A. NF - Kappa B signalingan alternate pathway for oxidative stress responses [ J ]. Cell Cycle,2003,2 : 9.
8Thanos Janosch, Miriam Schellerer, Thomas Seitz, et al. Characterization of IkB kinases [ J ]. .I Biot Chem, 1996, 271 (23) :13868.
9Chen F,Shi X. NF - KappaB, a pivotal transcription factor in silica induced diseases[ J]. Mol Cell Bioehem,2002,234:169.
10Vermeulen L, De Wilde G, Notebaert S, et al. Regulation of the transcriptional activity of the nuclear factor - KappaB p65 subunit[ J]. Biochem Pharmacol, 2002, 64. 963.
2Seinle AU,Weidenbach H, Wagner M, et al. NF-kB/Rel activation in caerulein pancreatitis[J]. Gastroenterology, 1999, 116 : 420-430.
3Bohrer H, Qiu F, Zimmermann T, et al. Role of NF-kappaB in the mortality of sepsis[J]. J Clin Invest, 1997, 100(5) : 972-985.
4Stanger BZ, Leder P, Lee TH, et al RIP: a movel protein containing a death domain that interacts with Fas/APO-I in yeast and causes cell death[J]. Cell 1995, 81 : 513.
5Algul H, TandoY, BelL M, et al. Different modes of NF-kappaB/Rel activation in pancreatic Iobules[J]. Am J Physiol Gastrointest Liver physiol 2002, 283(2): G270-281.
6Rakonczay Z,Jarmay K, Kaszaki J, et al. NF-kappaB activation is detrimental in arginine induced acute pancreatitis[J]. Froe Radic Biol Med,2003, 15; 34(6) : 696-709.
7Foulds S, Galustion C, Mansfield AO, et al. Transcription factor NF-kappaB expression and postsurgical organ dysfunction[J] Ann Surg 2001,233(1) : 70-78.
8Algul H, Tando Y, Schneider G, et al. Acute Experimental pancreatitis and NF-KappaB/Rel Activation[J]. Pancreatology, 2002, 2(6) : 503-509.
9Abraham E. NF-kappaB activotion[J] .Crit Care Med, 2000, 28(4) :N100-104.
10Kaiser AM, Sakuja AK, Lu L, et al. Effects of cytoheximide on pancreatitis enduclease activity, apoptosis, and serverity of acute pancreatitis [J]. Am J Physiol, 1996, 271(40) : C982.
3Witko-Sarsat V, Friedlander M, Capeillre-Blandin C, et al. Ad- vanced oxidation protein products as a novel marker of oxidative stressin wremia [J]. Kidney Int, 1996, 49(5): 1304-1313.
4Fialov6 L, KalousovO M, Soukupov6 J, et al. Markers of inflammation in preeclampsia [J]. Prague Med Rep, 2004, 105(3) : 301-310.
5Liu B, Hou X, Zhou Q, et al. Detection of advanced oxidation protein products in patients with chronic kidney disease by a novel monoclonal antibody [J]. Free Radic Res, 2011, 45(6) : 662-671.
6Zuwata-Jagieko J, Pazgan-Simon M, Simon K, et al. Advanced oxida- tion protein products and inflammatory markers in liver cirrhosis: a comparison between alcohol-related and HCV-related cirrhosis [ J ]. Aeta Biochim Pol, 2011, 58(1) : 59-65.
7Chen YH, Shi W, Liang XL, et al. Effect of blood sample type on the measurement of advanced oxidation protein products as a biomarker of inflammation and oxidative stress in hemodialysis patients [ J]. Biomar- kers, 2011, 16(2): 129-135.
